Target intelligence / Profile preview

Long non-coding RNA–protein interaction

Molecular classification
Other (Interaction Class), not a protein, receptor, enzyme, or similar
01

Overview

Long non-coding RNA–protein interactions describe the physical bindings between long non-coding RNAs (typically >200 nucleotides and not coding for protein) and RNA-binding proteins (RBPs). These interactions are central to many cellular processes, including gene expression regulation at the transcriptional and post-transcriptional levels, chromatin remodeling, mRNA splicing, epigenetic modification, and cellular response to stimuli. lncRNA–protein interactions are highly specific in many cases but form a vast and largely uncharacterized network across cell types and pathologies. Dysregulation of these interactions is implicated in diseases such as cancer, neurodegeneration, and immune disorders[1][2][3][4][5][6][7][8]. This term refers to a mechanistic class and not an individual target suitable for therapeutic intervention except in cases where a specific lncRNA–protein pair is identified as a disease driver. Note: This is not a single molecular target, but a class of macromolecular interactions. Use of this term as a “target” is non-specific and does not reflect a discrete, actionable drug target[2][3][5][6][7].

Other names
lncRNA–RBP interactionlncRNA–protein complexlncRNA–protein binding
02

Mechanism of action

Blocking or mimicking specific lncRNA–protein binding. Modulating lncRNA stability or expression (if targeting a specific pair; not for the class as a whole).

03

Biological functions

Chromatin regulationTranscriptional controlPost-transcriptional regulationmRNA splicing modulationProtein localizationEpigenetic modificationScaffold for ribonucleoprotein complex assembly
04

Disease associations

CancerImmune disordersNeurological diseasesCardiovascular diseasesOther (very broad; context dependent)
05

Safety considerations

Off-target effects due to lncRNAs' pleiotropic rolesLack of specificityUnintended disruption of normal gene regulation and cell functionPoor understanding of most lncRNAs' functions
06

Biomarkers

Specific lncRNAs and their binding proteins can be biomarkers (such as MALAT1, HOTAIR, NEAT1 lncRNAs in cancer), but there is no universal biomarker for the interaction class

Beyond the preview

Go deeper on Long non-coding RNA–protein interaction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long non-coding RNA–protein interaction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call